(VIANEWS) – TotalEnergiesGabon (EC.PA), AUSTEVOLL SEAFOOD (AUSS.OL), GROUPE CRIT (CEN.PA) have the highest dividend yield stocks on this list.
| Financial Asset | Forward Dividend Yield | Updated (EST) |
|---|---|---|
| TotalEnergiesGabon (EC.PA) | 26.25% | 2024-01-12 09:23:47 |
| AUSTEVOLL SEAFOOD (AUSS.OL) | 7.18% | 2024-01-12 08:24:47 |
| GROUPE CRIT (CEN.PA) | 5.59% | 2024-01-12 09:04:23 |
| BENFICA (SLBEN.LS) | 3.92% | 2024-01-12 08:22:59 |
| SANOFI (SAN.PA) | 3.81% | 2024-01-12 09:22:11 |
Several Euronext companies pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.
1. TotalEnergiesGabon (EC.PA)
26.25% Foward Dividend Yield
TotalEnergiesGabon’s last close was €155.40, 18.21% below its 52-week high of €190.00. Intraday change was -0.51%.
TotalEnergies EP Gabon Société Anonyme engages in the mining, exploration, and production of crude oil in Gabon. It also holds interests in operated and non-operated production fields. The company was formerly known as Total Gabon. The company was incorporated in 1949 and is headquartered in Port Gentil, Gabon. TotalEnergies EP Gabon Société Anonyme is a subsidiary of TotalEnergies SE.
Earnings Per Share
As for profitability, TotalEnergiesGabon has a trailing twelve months EPS of €71.92.
PE Ratio
TotalEnergiesGabon has a trailing twelve months price to earnings ratio of 2.17. Meaning, the purchaser of the share is investing €2.17 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 20.36%.
Volume
Today’s last reported volume for TotalEnergiesGabon is 211 which is 57.71% below its average volume of 499.
More news about TotalEnergiesGabon.
2. AUSTEVOLL SEAFOOD (AUSS.OL)
7.18% Foward Dividend Yield
AUSTEVOLL SEAFOOD’s last close was kr81.75, 31.42% under its 52-week high of kr119.20. Intraday change was 2.77%.
Austevoll Seafood ASA, a seafood company, engages in the salmon and trout, white fish, and pelagic businesses in Norway, the European Union, the United Kingdom, Eastern Europe, Africa, North America, Asia, South America, and internationally. The company is involved in the ownership and operation of fishing vessels, as well as farming, aquaculture, processing, sale, and distribution of salmon and trout. It also produces white fish products, freezing and canning plants, fish meals, and fish oils; omega-3 oil; and canned and frozen fish products. The company was incorporated in 1981 and is headquartered in Storebø, Norway. Austevoll Seafood ASA is a subsidiary of Laco AS.
Earnings Per Share
As for profitability, AUSTEVOLL SEAFOOD has a trailing twelve months EPS of kr0.78.
PE Ratio
AUSTEVOLL SEAFOOD has a trailing twelve months price to earnings ratio of 104.74. Meaning, the purchaser of the share is investing kr104.74 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.89%.
More news about AUSTEVOLL SEAFOOD.
3. GROUPE CRIT (CEN.PA)
5.59% Foward Dividend Yield
GROUPE CRIT’s last close was €74.60, 10.55% under its 52-week high of €83.40. Intraday change was -0.53%.
Groupe CRIT SA provides temporary work and recruitment services in France and internationally. The company offers temporary work and recruitment, and training and consulting services. It also provides airport assistance, such as ground solutions, congo handling, and technical assistance services, as well as offers engineering and maintenance services. Groupe CRIT SA was founded in 1962 and is headquartered in Paris, France.
Earnings Per Share
As for profitability, GROUPE CRIT has a trailing twelve months EPS of €6.2.
PE Ratio
GROUPE CRIT has a trailing twelve months price to earnings ratio of 12.19. Meaning, the purchaser of the share is investing €12.19 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.06%.
Yearly Top and Bottom Value
GROUPE CRIT’s stock is valued at €75.60 at 21:50 EST, under its 52-week high of €83.40 and way higher than its 52-week low of €57.80.
More news about GROUPE CRIT.
4. BENFICA (SLBEN.LS)
3.92% Foward Dividend Yield
BENFICA’s last close was €3.05, 26.33% under its 52-week high of €4.14. Intraday change was 0.34%.
Sport Lisboa e Benfica – Futebol, SAD operates a sports club in Portugal. The company was founded in 1904 and is headquartered in Lisbon, Portugal. Sport Lisboa e Benfica – Futebol, SAD operates as a subsidiary of Sport Lisboa e Benfica SGPS SA.
Earnings Per Share
As for profitability, BENFICA has a trailing twelve months EPS of €0.18.
PE Ratio
BENFICA has a trailing twelve months price to earnings ratio of 16.5. Meaning, the purchaser of the share is investing €16.5 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.79%.
Moving Average
BENFICA’s value is way below its 50-day moving average of €3.38 and way under its 200-day moving average of €3.66.
Revenue Growth
Year-on-year quarterly revenue growth grew by 14.7%, now sitting on 195.8M for the twelve trailing months.
More news about BENFICA.
5. SANOFI (SAN.PA)
3.81% Foward Dividend Yield
SANOFI’s last close was €95.65, 9.06% under its 52-week high of €105.18. Intraday change was 0.3%.
Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as dupixent, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition, it offers poliomyelitis, pertussis, and hib pediatric vaccines; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, cholera, yellow fever, and rabies vaccines. The company also provides cough, cold, and flu, allergy, and pain care products, as well as physical, mental, and digestive wellness products; and offers body lotions, anti-itch products, moisturizing and soothing lotions, body and foot creams, and eczema powders. Further, it has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301 for Parkinson's disease; Blackstone Life Sciences to develop pivotal studies and clinical development program; and Seagen Inc. to design, develop, and commercialize antibody-drug conjugates for cancer. Additionally, the company has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Skyhawk Therapeutics, Inc to discover and develop novel small molecules; and Amunix Pharmaceuticals, Inc for T-cell engagers and cytokine therapies. It also enters in a strategic collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.
Earnings Per Share
As for profitability, SANOFI has a trailing twelve months EPS of €7.22.
PE Ratio
SANOFI has a trailing twelve months price to earnings ratio of 13.21. Meaning, the purchaser of the share is investing €13.21 for every euro of annual earnings.
Moving Average
SANOFI’s worth is higher than its 50-day moving average of €87.45 and below its 200-day moving average of €96.04.
Volatility
SANOFI’s last week, last month’s, and last quarter’s current intraday variation average was 0.43%, 0.42%, and 1.21%.
SANOFI’s highest amplitude of average volatility was 0.61% (last week), 0.60% (last month), and 1.21% (last quarter).
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on May 30, 2023, the estimated forward annual dividend rate is 3.56 and the estimated forward annual dividend yield is 3.81%.
More news about SANOFI.
